Coronavirus Update: Superior Tolerability Was Behind Pfizer/BioNTech’s Vaccine Switch

Far Fewer Suffered Fever Symptoms

 
• By Scrip Team
  
Pfizer
Pfizer and BioNTech's vaccine candidate is expected to be one of the first to gain approval, potentially as early as October.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip